These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 4343629)

  • 1. Actions of papaverine and bulbocapnine on synaptic transmission in the nigro-striatal pathway in the rat.
    Gonzalez-Vegas JA
    J Physiol; 1972 Oct; 226(2):102P. PubMed ID: 4343629
    [No Abstract]   [Full Text] [Related]  

  • 2. Antagonism of dopamine-mediated inhibition in the nigro-striatal pathway: a mode of action of some catatonia-inducing drugs.
    Gonzalez-Vegas JA
    Brain Res; 1974 Nov; 80(2):219-28. PubMed ID: 4371023
    [No Abstract]   [Full Text] [Related]  

  • 3. [Some aspects of the physiological role of dopamine as a synaptic transmitter in basal ganglia and caudate nucleus].
    Kostowski W
    Acta Physiol Pol; 1972; 23():97-114. PubMed ID: 4338739
    [No Abstract]   [Full Text] [Related]  

  • 4. Role of GABA in the striatal output system: globus pallidus, nucleus entopeduncularis, substantia nigra and nucleus subthalamicus.
    Scheel-Krüger J; Magelund G; Olianas MC
    Adv Biochem Psychopharmacol; 1981; 30():165-86. PubMed ID: 7036675
    [No Abstract]   [Full Text] [Related]  

  • 5. Nigro-striatal pathway: stimulation-evoked release of ( 3 H)dopamine from caudate nucleus.
    Voigtlander PF; Moore KE
    Brain Res; 1971 Dec; 35(2):580-3. PubMed ID: 5135554
    [No Abstract]   [Full Text] [Related]  

  • 6. Alterations in nigral NMDA and GABAA receptor control of the striatal dopamine level after repetitive exposures to nitrogen narcosis.
    Lavoute C; Weiss M; Rostain JC
    Exp Neurol; 2008 Jul; 212(1):63-70. PubMed ID: 18452916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The neuroleptics. 2. Neurophysiology and neuropharmacology.
    Albe-Fessard D; Bradley PB; Gerschenfeld HM; Herz A; Krnjević K; Lodin Z; Marczynski TJ; Massion J; Meulders M; Poirier LJ; Salmoiraghi GC; Schlag J; Tauc L; Wall PD
    Mod Probl Pharmacopsychiatry; 1970; 5():12-22. PubMed ID: 4348144
    [No Abstract]   [Full Text] [Related]  

  • 8. Electrophysiological studies of GABAergic neurons in the basal ganglia: nigro-collicular, nigro-thalamic, and pallido-subthalamic neurons.
    Feger J
    Adv Biochem Psychopharmacol; 1981; 30():53-68. PubMed ID: 7331936
    [No Abstract]   [Full Text] [Related]  

  • 9. Recent finding on dopaminergic transmission in the basal ganglia.
    Glowinski J
    Adv Neurol; 1990; 53():67-73. PubMed ID: 2173377
    [No Abstract]   [Full Text] [Related]  

  • 10. Dynamic utilization of GABA in substantia nigra: regulation by dopamine and GABA in the striatum, and its clinical and behavioral implications.
    Gale K; Casu M
    Mol Cell Biochem; 1981 Sep; 39():369-405. PubMed ID: 6118827
    [No Abstract]   [Full Text] [Related]  

  • 11. Lesions of the nigro-striatal dopamine pathway: effects on the storage and metabolism of striatal dopamine.
    Goldstein M; Ceasar P; Anagnoste B
    Pharmacol Ther B; 1976; 2(1):89-95. PubMed ID: 131326
    [No Abstract]   [Full Text] [Related]  

  • 12. A synaptic mechanism underlying the behavioral abnormalities induced by manganese intoxication.
    Calabresi P; Ammassari-Teule M; Gubellini P; Sancesario G; Morello M; Centonze D; Marfia GA; Saulle E; Passino E; Picconi B; Bernardi G
    Neurobiol Dis; 2001 Jun; 8(3):419-32. PubMed ID: 11442351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of nigro-striatal dopaminergic neurotransmission in the rat.
    Dray A; Fowler LJ; Oakley NR; Simmonds MA; Tanner T
    Neuropharmacology; 1977; 16(7-8):511-8. PubMed ID: 199852
    [No Abstract]   [Full Text] [Related]  

  • 14. Electrophysiology of the nigro-putamen dopamine pathway.
    York DH
    Pharmacol Ther B; 1976; 2(1):1-7. PubMed ID: 772715
    [No Abstract]   [Full Text] [Related]  

  • 15. Interactions of dopaminergic and GABAergic neurotransmission: impact of 6-hydroxydopamine lesions into the substantia nigra of rats.
    Hossain MA; Weiner N
    J Pharmacol Exp Ther; 1995 Oct; 275(1):237-44. PubMed ID: 7562556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Striatal dysfunction increases basal ganglia output during motor cortex activation in parkinsonian rats.
    Belluscio MA; Riquelme LA; Murer MG
    Eur J Neurosci; 2007 May; 25(9):2791-804. PubMed ID: 17561844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nigro-neostriatal projection. A correlative study with Fink-Heimer impregnation, fluorescence histochemistry and electron microscopy.
    Ibata Y; Nojyo Y; Matsuura T; Sano Y
    Z Zellforsch Mikrosk Anat; 1973 Apr; 138(3):333-44. PubMed ID: 4574742
    [No Abstract]   [Full Text] [Related]  

  • 18. Role of GABA neurons in the expression of striatal motor functions.
    Di Chiara G; Porceddu ML; Imperato A; Morelli M
    Adv Biochem Psychopharmacol; 1981; 30():129-63. PubMed ID: 7036674
    [No Abstract]   [Full Text] [Related]  

  • 19. Distinct regional differences in dopamine-mediated volume transmission.
    Rice ME
    Prog Brain Res; 2000; 125():277-90. PubMed ID: 11098664
    [No Abstract]   [Full Text] [Related]  

  • 20. Substantia nigra glutamate antagonists produce contralateral turning and basal ganglia Fos expression: interactions with D1 and D2 dopamine receptor agonists.
    McPherson RJ; Marshall JF
    Synapse; 2000 Jun; 36(3):194-204. PubMed ID: 10819899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.